Stifel Financial’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,721
| Closed | -$2K | – | 3432 |
|
|
2022
Q3 | $2K | Sell |
13,721
-425,544
| -97% | -$62K | ﹤0.01% | 3269 |
|
|
2022
Q2 | $264K | Buy |
439,265
+147,267
| +50% | +$88.5K | ﹤0.01% | 2820 |
|
|
2022
Q1 | $385K | Buy |
291,998
+5,739
| +2% | +$7.57K | ﹤0.01% | 2726 |
|
|
2021
Q4 | $747K | Sell |
286,259
-6,581
| -2% | -$17.2K | ﹤0.01% | 2332 |
|
|
2021
Q3 | $911K | Buy |
292,840
+30,147
| +11% | +$93.8K | ﹤0.01% | 2163 |
|
|
2021
Q2 | $977K | Buy |
262,693
+16,806
| +7% | +$62.5K | ﹤0.01% | 2122 |
|
|
2021
Q1 | $851K | Buy |
245,887
+35,762
| +17% | +$124K | ﹤0.01% | 2099 |
|
|
2020
Q4 | $706K | Buy |
210,125
+22,288
| +12% | +$74.9K | ﹤0.01% | 2097 |
|
|
2020
Q3 | $659K | Buy |
187,837
+10,651
| +6% | +$37.4K | ﹤0.01% | 1915 |
|
|
2020
Q2 | $815K | Sell |
177,186
-682
| -0.4% | -$3.14K | ﹤0.01% | 1706 |
|
|
2020
Q1 | $566K | Buy |
177,868
+14,825
| +9% | +$47.2K | ﹤0.01% | 1782 |
|
|
2019
Q4 | $981K | Sell |
163,043
-40,415
| -20% | -$243K | ﹤0.01% | 1846 |
|
|
2019
Q3 | $844K | Buy |
203,458
+130,497
| +179% | +$541K | ﹤0.01% | 1859 |
|
|
2019
Q2 | $951K | Buy |
+72,961
| New | +$951K | ﹤0.01% | 1838 |
|